蒙大拿 的 頭頸部鱗狀細胞癌 臨床試驗
5 項針對 頭頸部鱗狀細胞癌 的研究正在 蒙大拿 各地點尋找參與者。
蒙大拿 的城市
官方研究文本（英文）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06992427Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06589804BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 3 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT05136196Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Benefis Sletten Cancer Institute, Great Falls
- Logan Health Medical Center, Kalispell
- Community Medical Center, Missoula
招募中2 期
18 至 79 歲 · 所有性別 · 更新於 2026年9月22日 · NCT04671667Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 還有 7 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT02734537資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。